post-add

Cumulative Covid Vaccination Coverage Exceeds 190.34 Cr

India’s Covid-19 vaccination coverage has exceeded 190.34 crore (1,90,34,90,396) as per provisional reports till 7 am today. This has been achieved through 2,36,58,273 sessions.

Covid-19 vaccination for the age group 12-14 years was started on 16 March, 2022. So far, more than 3.05 crore (3,05,07,974) adolescents have been administered the first dose of the Covis-19 vaccine. Similarly, the Covid-19 precaution dose administration for age group 18-59 years also started from 10th April, 2022 onwards.

The break-up of the cumulative figure as per the provisional report till 7 am today include:

Cumulative Vaccine Dose Coverage

HCWs

1st Dose

1,04,05,810

2nd Dose

1,00,24,711

Precaution Dose

49,34,574

FLWs

1st Dose

1,84,16,912

2nd Dose

1,75,55,305

Precaution Dose

79,51,396

Age Group 12-14 years

1st Dose

3,05,07,974

2nd Dose

98,85,187

Age Group 15-18 years

1st Dose

5,87,39,456

2nd Dose

4,32,18,084

Age Group 18-44 years

1st Dose

55,62,54,427

2nd Dose

48,20,42,776

Precaution Dose

2,87,204

Age Group 45-59 years

1st Dose

20,30,56,775

2nd Dose

18,89,79,847

Precaution Dose

8,07,506

Over 60 years

1st Dose

12,69,65,076

2nd Dose

11,77,68,750

Precaution Dose

1,56,88,626

Precaution Dose

2,96,69,306

Total

1,90,34,90,396


India’s active caseload currently stands at 20,403. Active cases now constitute 0.05 per cent of the country's total positive cases.

Consequently, India’s recovery rate stands at 98.74 per cent. 3,410 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,25,60,905.

3,207 new cases were reported in the last 24 hours.

The last 24 hours saw a total of 3,36,776 Covid-19 tests being conducted. India has so far conducted over 84.10 crore (84,10,29,858) cumulative tests.

Weekly positivity rate in the country currently stands at 0.82 per cent and the daily positivity rate is also reported to be 0.95 per cent.


(PIB)

Also Read

Subscribe to our newsletter to get updates on our latest news